The Biological Intellectual Property Protection Act of 2025 aims to restrict the export of synthetic DNA and RNA sequences to foreign entities of.
The Biological Intellectual Property Protection Act of 2025 seeks to safeguard U.S. intellectual property and sensitive information related to synthetic biology by imposing a license requirement for the export, reexport, or in-country transfer of digital sequences of synthetic DNA or RNA to foreign entities of concern. This bill addresses concerns about the potential for intellectual property theft by foreign adversaries, particularly those from countries like the People's Republic of China, which are actively seeking to exploit U.S.
Included in complete analysis
- Overview
- Core Provisions
- Implementation
- Impact
- Legal Framework
- Critical Issues
See what it does, who it affects, and the critical issues in plain language. Free, 30 seconds.